January 2006


Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

13585.  Bhan MK, Bahl R, Bhatnagar S. Typhoid and paratyphoid fever. Lancet. 2005 Aug 27-Sep 2;366(9487):749-62.


13586.  Kirkpatrick BD, Tenney KM, Larsson CJ, O'Neill JP, Ventrone C, Bentley M, Upton A, Hindle Z, Fidler C, Kutzko D, Holdridge R, Lapointe C, Hamlet S, Chatfield SN. The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations. J Infect Dis. 2005 Aug 1;192(3):360-6.

13587.   von Seidlein L. The need for another typhoid fever vaccine.J Infect Dis. 2005 Aug 1;192(3):357-9.



April 2006


Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

14164.   Hasan R, Cooke FJ, Nair S, Harish BN, Wain J. Typhoid and paratyphoid fever. Lancet. 2005 Nov 5;366(9497):1603-4.

14165.   Renuka K, Sood S, Das BK, Kapil A. High-level ciprofloxacin resistance in Salmonella enterica serotype Typhi in India. J Med Microbiol. 2005 Oct;54(Pt 10):999-1000.

14166.  Weinberger M, Keller N. Recent trends in the epidemiology of non-typhoid Salmonella and antimicrobial resistance: the Israeli experience and worldwide review. Curr Opin Infect Dis. 2005 Dec;18(6):513-21. Review.


14167.    Acosta CJ, Galindo CM, Ali M, Elyazeed RA, Ochiai RL, Danovaro-Holliday MC, Page AL, Thiem VD, Jin Y, Park JK, Lee H, Puri MK, Ivanoff B, Agtini MD, Soeharno R, Simanjuntak CH, Punjabi NH, Canh do G, Sur D, Nizami Q, Manna B, Bai-qing D, Anh DD, Honghui Y, Bhattacharya SK, Bhutta Z, Trach DD, Xu ZY, Pang T, Donner A, Clemens JD.  A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design. Trop Med Int Health. 2005 Dec;10(12):1219-28.

14168.   Basnyat B. Typhoid and paratyphoid fever. Lancet. 2005 Nov 5;366(9497):1603.

14169.  Unal A, Sutlas PN. Clinical and radiological features of symptomatic central nervous system tuberculomas. Eur J Neurol. 2005 Oct;12(10):797-804. 



July 2006


Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

14556.  Lai CH, Huang CK, Chin C, Lin HH, Chi CY, Chen HP. Acute acalculous cholecystitis: A rare presentation of typhoid fever in adults. Scand J Infect Dis. 2006;38(3):196-200. Review.


14557. Cailhol J, Lailler R, Bouvet P, La Vieille S, Gauchard F, Sanders P, Brisabois A. Trends in antimicrobial resistance phenotypes in non-typhoid Salmonellae from human and poultry origins in France. Epidemiol Infect. 2006 Feb;134(1):171-8.

14558. Raffatellu M, Chessa D, Wilson RP, Tukel C, Akcelik M, Baumler AJ.Capsule-mediated immune evasion: a new hypothesis explaining aspects of typhoid fever pathogenesis. Infect Immun. 2006 Jan;74(1):19-27.


14559. Chen X, Stanton B, Wang X, Nyamette A, Pach A, Kaljee L, Pack R, von Seidlein L, Clemens J, Gong Y, Mao R. Differences in perception of dysentery and enteric fever and willingness to receive vaccines among rural residents in China. Vaccine. 2006 Jan 30;24(5):561-71.

14560. Kirkpatrick BD, McKenzie R, O'Neill JP, Larsson CJ, Bourgeois AL, Shimko J, Bentley M, Makin J, Chatfield S, Hindle Z, Fidler C, Robinson BE, Ventrone CH, Bansal N, Carpenter CM, Kutzko D, Hamlet S, LaPointe C, Taylor DN. Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers. Vaccine. 2006 Jan 12;24(2):116-23.

14561. Spreng S, Dietrich G, Weidinger G. Rational design of Salmonella-based vaccination strategies. Methods. 2006 Feb;38(2):133-43.



October 2006

Some selected abstract:


Papagrigorakis MJ, Yapijakis C, Synodinos PN, Baziotopoulou-Valavani E.  DNA examination of ancient dental pulp incriminates typhoid fever as a probable cause of the Plague of Athens. Int J Infect Dis. 2006 May;10(3):206-14.

Department of Orthodontics, Dental School, University of Athens, 2 Thivon str., 11527 Goudi/Athens, Greece. manjpap@dent.uoa.gr


BACKGROUND: Until now, in the absence of direct microbiological evidence, the cause of the Plague of Athens has remained a matter of debate among scientists who have relied exclusively on Thucydides' narrations to introduce several possible diagnoses. A mass burial pit, unearthed in the Kerameikos ancient cemetery of Athens and dated back to the time of the plague outbreak (around 430 BC), has provided the required skeletal material for the investigation of ancient microbial DNA. OBJECTIVE: To determine the probable cause of the Plague of Athens. METHOD: Dental pulp was our material of choice, since it has been proved to be an ideal DNA source of ancient septicemic microorganisms through its good vascularization, durability and natural sterility. RESULTS: Six DNA amplifications targeted at genomic parts of the agents of plague (Yersinia pestis), typhus (Rickettsia prowazekii), anthrax (Bacillus anthracis), tuberculosis (Mycobacterium tuberculosis), cowpox (cowpox virus) and cat-scratch disease (Bartonella henselae) failed to yield any product in 'suicide' reactions of DNA samples isolated from three ancient teeth. On the seventh such attempt, DNA sequences of Salmonella enterica serovar Typhi were identified providing clear evidence for the presence of that microorganism in the dental pulp of teeth recovered from the Kerameikos mass grave. CONCLUSION: The results of this study clearly implicate typhoid fever as a probable cause of the Plague of Athens.

Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics:

14910.  Cunha BA. Typhoid fever: the temporal relations of key clinical diagnostic points. Lancet Infect Dis. 2006 Jun;6(6):318-20; author reply 320-1.

14911.  Salve A, Pichel M, Wiesner M, Hidalgo M, Terragno R, Alvarez A, Agudelo CI, Castaneda E, Binsztein N. Molecular subtyping of Salmonella enterica serovar Typhi isolates from Colombia and Argentina. Foodborne Pathog Dis. 2006 Spring;3(1):142-52.

14912.  Shirakawa T, Acharya B, Kinoshita S, Kumagai S, Gotoh A, Kawabata M.  Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003. Diagn Microbiol Infect Dis. 2006 Apr;54(4):299-303.

14913.  Williams SJ 2nd. Validation of aggressive surgical approach to intestinal typhoid perforation: a "new" and useful physical sign for peritonitis. Am J Surg. 2006 Apr;191(4):566.


14914.  Do GC, Whittington D, Le TK, Utomo N, Nguyen TH, Poulos C, Dang TD, Kim D, Nyamete A, Acosta C. Household demand for typhoid fever vaccines in Hue, Vietnam. Health Policy Plan. 2006 May;21(3):241-55.    


14915.  Rahman M, Siddique AK, Shoma S, Rashid H, Salam MA, Ahmed QS, Nair GB, Breiman RF.  Emergence of multidrug-resistant Salmonella enterica serotype Typhi with decreased ciprofloxacin susceptibility in Bangladesh. Epidemiol Infect. 2006Apr;134(2):433-8.

14916.  Threlfall EJ, Day M, de Pinna E, Lewis H, Lawrence J. Drug-resistant enteric fever in the UK. Lancet. 2006 May 13;367(9522):1576.